Cirrhosis News and Research

Latest Cirrhosis News and Research

Study could pave the way for potential urine test to diagnose liver fibrosis

Fifty fragments of proteins, termed peptides, have been identified in the urine of liver fibrosis patients in a new study that could pave the way for a potential diagnostic urine test for the condition if further validated.

16 Nov 2020

Study reveals new source of abnormal lymphatic flow that may account for plastic bronchitis

Interventional radiologists with Nemours Children's Health System have identified a new source of abnormal lymphatic flow between the liver and the lungs that may be responsible for some cases of plastic bronchitis.

11 Nov 2020

A substantial minority of middle-aged adults have liver fibrosis

A substantial minority of participants from the Framingham Heart Study, (nearly nine percent), had potentially clinically significant liver fibrosis (scarring). This the first study of this size and scale done in the United States.

9 Nov 2020

SARS-CoV-2 viral antigens found in non-pulmonary tissues in recovering patients

A team of researchers in Singapore, led by Dr. Joe Yeong, and Prof. Tony Kiat Hon Lim, have reported the presence of residual SARS-CoV-2 ribonucleic acid (RNA) – the virus' genetic material – in stool samples and gastrointestinal tissues from patients recovering from the coronavirus disease 2019 (COVID-19).

8 Nov 2020

Dietary supplement helps prevent fatty liver disease in rats

A recent study by researchers at the University of Jyväskylä was successful in partially preventing fatty liver disease in rats.

4 Nov 2020

Dietary restriction effective in reducing the odds of developing liver cancer from fatty liver

Liver cancer from too much fat accumulation in the liver has been increasing in many countries including Japan.

29 Oct 2020

Researchers apply a novel technique to improve understanding of liver disease, immune activation

Human cells are encased by a membrane coated with diverse sugar molecules known as glycans. These glycans play many roles in health and disease, making them important to understand.

20 Oct 2020

Serum metabolite profile can help identify individuals at risk of alcohol-related disease

A new study from the University of Eastern Finland is the first in the world to show that the serum metabolite profile can be used to identify individuals likely at risk of developing an alcohol-related disease in the future.

19 Oct 2020

Start-up receives NIH grant to accelerate development of contrast agent to detect liver fibrosis

Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents' Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease.

15 Oct 2020

Even mild fatty liver disease associated with higher risk of all-cause mortality

Non-alcoholic fatty liver disease, NAFLD, affects nearly one in four adults in Europe and the U.S. Earlier research has demonstrated an increased risk of death in patients with NAFLD and advanced fibrosis or cirrhosis.

12 Oct 2020

Study highlights need for culturally relevant programs to educate Black communities on hepatitis B

Hepatitis B disproportionately impacts U.S. Blacks, including African American and Haitian Blacks. Both communities suffer from widespread misinformation and access to care issues that might avert disease detection and prevention, according to a study published in Cancer Causes & Control by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

12 Oct 2020

Skoltech researchers identify new panel of potential biomarkers for liver cancer diagnosis

A group of Skoltech scientists led by a Skoltech and MSU professor Olga Dontsova discovered a novel liver-specific non-coding RNA.

30 Sep 2020

Owlstone Medical releases positive study results on use of breath biopsy for better liver disease diagnosis

Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.

From Owlstone Medical Ltd 23 Sep 2020

Cirrhosis News and Research

Latest Cirrhosis News and Research

Study could pave the way for potential urine test to diagnose liver fibrosis

Study reveals new source of abnormal lymphatic flow that may account for plastic bronchitis

A substantial minority of middle-aged adults have liver fibrosis

SARS-CoV-2 viral antigens found in non-pulmonary tissues in recovering patients

Dietary supplement helps prevent fatty liver disease in rats

Dietary restriction effective in reducing the odds of developing liver cancer from fatty liver

Researchers apply a novel technique to improve understanding of liver disease, immune activation

Serum metabolite profile can help identify individuals at risk of alcohol-related disease

Start-up receives NIH grant to accelerate development of contrast agent to detect liver fibrosis

Even mild fatty liver disease associated with higher risk of all-cause mortality

Study highlights need for culturally relevant programs to educate Black communities on hepatitis B

Skoltech researchers identify new panel of potential biomarkers for liver cancer diagnosis

Owlstone Medical releases positive study results on use of breath biopsy for better liver disease diagnosis

Drug for liver cirrhosis shows potential to treat dementia and motor neuron disease

Study identifies gene that could decrease chances of developing alcoholic cirrhosis

Study identifies three clinical course variations in patients with acute decompensated cirrhosis

New discovery could help protect the liver from fructose-induced diseases

Researchers identify how promising therapy may work to improve adverse effects of NAFLD

Researchers identify three forms of disease progression for acute decompensated liver cirrhosis

Excessive fructose consumption can result in non-alcoholic fatty liver disease

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Cirrhosis News and Research

Latest Cirrhosis News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in